Back to results
US 2013/0157962 A1Published application
Methods for inhibiting growth of prolactin-responsive cancer cells with cyclosporine a or other cyclophilin inhibitors
AssigneeThe Trustees of the University of Pennsylvania
InventorCharles V. Clevenger
Life of this patent
Estimating the term…
Abstract
Methods are provided for inhibiting growth of prolactin-responsive cancer cells and treating prolactin-responsive malignancies via administration an agent such as cyclosporine A which directly inhibits an enzymatic activity of a cyclophilin.
Claims14
A method for inhibiting growth of prolactin-responsive cancer cells comprising administering to the cells an agent which directly inhibits an enzymatic activity of a cyclophilin.
A method for treating a prolactin-responsive malignancy in a subject comprising administering to the subject an agent which directly inhibits an enzymatic activity of cyclophilins.
Dependencies are inferred from the claim text.